Transdermal Therapeutics: Emerging Approaches and the Road Ahead

Abstract

Transdermal drug delivery (TDD) has evolved from simple adhesive patches toward highly engineered platforms that enable delivery of small molecules, peptides/proteins, vaccines and even cells. Till now the field progressed through optimization of passive patches and chemical enhancers, emergence and clinical translation of new patch medicines, rapid growth in physical enhancement techniques (microneedles, iontophoresis, sonophoresis, electroporation), integration of nanocarriers and responsive materials, and development of wearable/smart systems with closed loop control. In recent years, research has increasingly focused on understanding the skin’s complex barrier properties and leveraging this knowledge to design more effective delivery systems. Advances in material science have enabled the creation of patches with improved adhesion, sustained release characteristics, and enhanced biocompatibility. Microneedle technologies have broadened the therapeutic possibilities by enabling painless penetration of the stratum corneum while minimizing infection risks and discomfort. Meanwhile, physical enhancement techniques have matured into clinically viable tools, providing precise control over dose and timing. The incorporation of stimuli responsive polymers, lipid based nanocarriers, and hydrogel matrices has significantly expanded the range of drugs that can be transported transdermally, including fragile biological molecules. Wearable platforms with sensors and feedback loops have paved the way for personalized medicine, enabling real time monitoring and automated drug release tailored to patient needs. This review summarizes major advances, clinical translation, regulatory milestones, mechanistic insights, remaining challenges, and future directions, emphasizing literature and examples.